GOLDMAN SACHS GROUP INC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 70 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$9,221,000
-35.9%
1,905,276
+40.7%
0.00%
-25.0%
Q4 2019$14,389,000
+0.3%
1,353,688
-1.7%
0.00%0.0%
Q3 2019$14,339,000
-36.5%
1,377,457
-6.6%
0.00%
-42.9%
Q2 2019$22,592,000
+28.9%
1,474,653
+8.1%
0.01%
+40.0%
Q1 2019$17,527,000
+4586.4%
1,363,968
+3363.8%
0.01%
Q4 2018$374,000
+15.1%
39,378
+101.1%
0.00%
Q3 2018$325,000
-14.2%
19,580
-17.0%
0.00%
Q2 2018$379,000
+13.8%
23,583
+8.4%
0.00%
Q1 2018$333,000
-65.7%
21,761
-75.1%
0.00%
Q3 2017$970,000
+634.8%
87,422
+619.0%
0.00%
Q3 2016$132,000
+144.4%
12,158
+4.9%
0.00%
Q1 2016$54,000
-50.0%
11,592
-32.0%
0.00%
Q4 2015$108,000
-97.4%
17,058
-96.3%
0.00%
-100.0%
Q3 2015$4,119,000
-24.1%
466,476
+1.2%
0.00%
-50.0%
Q2 2015$5,425,000
-18.8%
460,928
-0.2%
0.00%0.0%
Q1 2015$6,682,000
-18.7%
461,799
-4.1%
0.00%
-33.3%
Q4 2014$8,214,000
+122.4%
481,511
+62.4%
0.00%
+200.0%
Q3 2014$3,693,000
-23.9%
296,417
-10.4%
0.00%
-50.0%
Q2 2014$4,855,000
-6.5%
330,914
+29.8%
0.00%0.0%
Q1 2014$5,193,000
+20.3%
255,026
+15.8%
0.00%
+100.0%
Q4 2013$4,317,000
-56.8%
220,263
-0.3%
0.00%
-75.0%
Q3 2013$10,004,000
+815.3%
220,853
+381.9%
0.00%
Q2 2013$1,093,00045,8270.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders